Conexeu Sciences Inc.
CNXU
Sync financial data to generate a health grade for this company.
Analytical Summary
Review the statement evidence below to form a view on CNXU.
6-Year Financial Trajectory
QuarterlyStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q2 FY2026 Apr 30, 2026 10-Q ↗ | Q1 FY2026 Jan 31, 2026 10-Q ↗ | Q4 FY2025 Oct 31, 2025 10-Q ↗ | Q2 FY2025 Apr 30, 2025 10-Q ↗ | Q1 FY2025 Feb 1, 2025 10-Q ↗ | Q4 FY2024 Oct 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|
| EPS Growth YoY (%) |
-120.0%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — | — |
| Net Income Growth YoY (%) |
-403.1%
Weak
Weak
Year-over-year change in net income |
— | — | — | — | — |
| Metric | Q2 FY2026 Apr 30, 2026 10-Q ↗ | Q1 FY2026 Jan 31, 2026 10-Q ↗ | Q4 FY2025 Oct 31, 2025 10-Q ↗ | Q2 FY2025 Apr 30, 2025 10-Q ↗ | Q1 FY2025 Feb 1, 2025 10-Q ↗ | Q4 FY2024 Oct 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|
| Effective Tax Rate (%) (%) |
0.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— | — |
0.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— | — |
| Metric | Q2 FY2026 Apr 30, 2026 10-Q ↗ | Q1 FY2026 Jan 31, 2026 10-Q ↗ | Q4 FY2025 Oct 31, 2025 10-Q ↗ | Q2 FY2025 Apr 30, 2025 10-Q ↗ | Q1 FY2025 Feb 1, 2025 10-Q ↗ | Q4 FY2024 Oct 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|
| Return on Invested Capital (%) |
-33.1%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
-258.6%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
| Return on Capital (%) (%) |
-29.0%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — | — | — |
| Return on Common Equity (%) (%) |
-32.0%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-313%)
|
— | — |
-259.2%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-1828%)
|
— | — |
| Metric | Q2 FY2026 Apr 30, 2026 10-Q ↗ | Q1 FY2026 Jan 31, 2026 10-Q ↗ | Q4 FY2025 Oct 31, 2025 10-Q ↗ | Q2 FY2025 Apr 30, 2025 10-Q ↗ | Q1 FY2025 Feb 1, 2025 10-Q ↗ | Q4 FY2024 Oct 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|
| Interest Coverage (x) | — | — | — |
-330.43x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— | — |
| Net Debt (USD) | $-6.85M | — | $-4.81M | — | — | — |
Secondary lens
Benchmark Lens
Compare CNXU against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare CNXU against peers after checking the statement evidence.
Compare CNXU with peers
Stack CNXU against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago